Placebo, pemetrexed 500 mg/m2, and investigators choice of cisplatin 75 mg/m2 or carboplatin AUC 5 mg/mL/min intravenously on Day 1 of each 21-day cycle for 4 cycles followed by placebo and pemetrexed 500 mg/m2 intravenously every 3 weeks
Remember: side effects are temporary, results are substantial
Comparing peptide approaches to bone healing With multiple peptides showing potential for bone healing, choosing the right approach requires understanding how they compare across key factors
A c c e p t e d : May 8, 2015
Namely, the beneficial effect of L-arginine brings down aggravation by NOS-blockade with L-NAME to the control levels
This result is consistent with those of previous reports, supporting the notion that the TAD2 region plays a substantial role in the interaction with FOXO4 FHD 38